Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer von Moore, Kathleen, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Banerjee, Susana, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William, Mathews, Cara, Liu, Joyce, Lowe, Elizabeth S, Bloomfield, Ralph, DiSilvestro, Paul

Volltext

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer von Ray-Coquard, Isabelle, Pautier, Patricia, Pignata, Sandro, Pérol, David, González-Martín, Antonio, Berger, Regina, Fujiwara, Keiichi, Vergote, Ignace, Colombo, Nicoletta, Mäenpää, Johanna, Selle, Frédéric, Sehouli, Jalid, Lorusso, Domenica, Guerra Alía, Eva M, Reinthaller, Alexander, Nagao, Shoji, Lefeuvre-Plesse, Claudia, Canzler, Ulrich, Scambia, Giovanni, Lortholary, Alain, Marmé, Frederik, Combe, Pierre, de Gregorio, Nikolaus, Rodrigues, Manuel, Buderath, Paul, Dubot, Coraline, Burges, Alexander, You, Benoît, Pujade-Lauraine, Eric, Harter, Philipp

Volltext

Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study von Nené, Nuno R, PhD, Reisel, Daniel, PhD, Leimbach, Andreas, PhD, Franchi, Dorella, MD, Jones, Allison, BSc, Evans, Iona, PhD, Knapp, Susanne, PhD, Ryan, Andy, PhD, Ghazali, Shohreh, MSc, Timms, John F, DPhil, Paprotka, Tobias, PhD, Bjørge, Line, Prof, Zikan, Michal, Prof, Cibula, David, Prof, Colombo, Nicoletta, Prof, Widschwendter, Martin, Prof

Volltext

Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future von Colombo, Nicoletta, Lorusso, Domenica, Scollo, Paolo

Volltext

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up von Colombo, Nicoletta, Creutzberg, Carien, Amant, Frederic, Bosse, Tjalling, González-Martín, Antonio, Ledermann, Jonathan, Marth, Christian, Nout, Remi, Querleu, Denis, Mirza, Mansoor Raza, Sessa, Cristiana

Volltext

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39) von Moore, Kathleen N, Bookman, Michael, Sehouli, Jalid, Miller, Austin, Anderson, Charles, Scambia, Giovanni, Myers, Tashanna, Taskiran, Cagatay, Robison, Katina, Mäenpää, Johanna, Willmott, Lyndsay, Colombo, Nicoletta, Thomes-Pepin, Jessica, Liontos, Michalis, Gold, Michael A, Garcia, Yolanda, Sharma, Sudarshan K, Darus, Christopher J, Aghajanian, Carol, Okamoto, Aikou, Wu, Xiaohua, Safin, Rustem, Wu, Fan, Molinero, Luciana, Maiya, Vidya, Khor, Victor K, Lin, Yvonne G, Pignata, Sandro

Volltext

The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples von Barrett, James E., Herzog, Chiara, Jones, Allison, Leavy, Olivia C., Evans, Iona, Knapp, Susanne, Reisel, Daniel, Nazarenko, Tatiana, Kim, Yoo-Na, Franchi, Dorella, Ryan, Andy, Franks, Joanna, Bjørge, Line, Zikan, Michal, Cibula, David, Harbeck, Nadia, Colombo, Nicoletta, Dudbridge, Frank, Jones, Louise, Sundström, Karin, Dillner, Joakim, Rådestad, Angelique Flöter, Gemzell-Danielsson, Kristina, Pashayan, Nora, Widschwendter, Martin

Volltext

Management of Ovarian Stromal Cell Tumors von Colombo, Nicoletta, Parma, Gabriella, Zanagnolo, Vanna, Insinga, Alessandra

Volltext

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial von Oza, Amit M, Prof, Cibula, David, Prof, Benzaquen, Ana Oaknin, MD, Poole, Christopher, Prof, Mathijssen, Ron H J, Prof, Sonke, Gabe S, MD, Colombo, Nicoletta, MD, Špaček, Jiří, MD, Vuylsteke, Peter, MD, Hirte, Holger, MD, Mahner, Sven, MD, Plante, Marie, MD, Schmalfeldt, Barbara, Prof, Mackay, Helen, MD, Rowbottom, Jacqui, PhD, Lowe, Elizabeth S, MD, Dougherty, Brian, PhD, Barrett, J Carl, PhD, Friedlander, Michael, Prof

Volltext

Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient von Colombo, Nicoletta

Volltext

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma von Concin, Nicole, Creutzberg, Carien L., Vergote, Ignace, Cibula, David, Mirza, Mansoor Raza, Marnitz, Simone, Ledermann, Jonathan A., Bosse, Tjalling, Chargari, Cyrus, Fagotti, Anna, Fotopoulou, Christina, González-Martín, Antonio, Lax, Sigurd F., Lorusso, Domenica, Marth, Christian, Morice, Philippe, Nout, Remi A., O’Donnell, Dearbhaile E., Querleu, Denis, Raspollini, Maria Rosaria, Sehouli, Jalid, Sturdza, Alina E., Taylor, Alexandra, Westermann, Anneke M., Wimberger, Pauline, Colombo, Nicoletta, Planchamp, François, Matias-Guiu, Xavier

Volltext

Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA mutational status von Tomao, Federica, Bardhi, Erlisa, Di Pinto, Anna, Sassu, Carolina Maria, Biagioli, Elena, Petrella, Maria Cristina, Palaia, Innocenza, Muzii, Ludovico, Colombo, Nicoletta, Panici, Pierluigi Benedetti

Volltext

Incorporation of pazopanib in maintenance therapy of ovarian cancer von du Bois, Andreas, Floquet, Anne, Kim, Jae-Weon, Rau, Joern, del Campo, Josep M, Friedlander, Michael, Pignata, Sandro, Fujiwara, Keiichi, Vergote, Ignace, Colombo, Nicoletta, Mirza, Mansoor R, Monk, Bradley J, Kimmig, Rainer, Ray-Coquard, Isabelle, Zang, Rongyu, Diaz-Padilla, Ivan, Baumann, Klaus H, Mouret-Reynier, Marie-Ange, Kim, Jae-Hoon, Kurzeder, Christian, Lesoin, Anne, Vasey, Paul, Marth, Christian, Canzler, Ulrich, Scambia, Giovanni, Shimada, Muneaki, Calvert, Paula, Pujade-Lauraine, Eric, Kim, Byoung-Gie, Herzog, Thomas J, Mitrica, Ionel, Schade-Brittinger, Carmen, Wang, Qiong, Crescenzo, Rocco, Harter, Philipp

Volltext

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial von du Bois, Andreas, Prof, Kristensen, Gunnar, Prof, Ray-Coquard, Isabelle, Prof, Reuss, Alexander, MSc, Pignata, Sandro, MD, Colombo, Nicoletta, Prof, Denison, Ursula, MD, Vergote, Ignace, Prof, del Campo, Jose M, MD, Ottevanger, Petronella, PhD, Heubner, Martin, MD, Minarik, Thomas, PhD, Sevin, Emmanuel, MD, de Gregorio, Nikolaus, MD, Bidziński, Mariusz, Prof, Pfisterer, Jacobus, Prof, Malander, Susanne, MD, Hilpert, Felix, Prof, Mirza, Mansoor R, MD, Scambia, Giovanni, Prof, Meier, Werner, Prof, Nicoletto, Maria O, MD, Bjørge, Line, Prof, Lortholary, Alain, MD, Sailer, Martin Oliver, PhD, Merger, Michael, MD, Harter, Philipp, MD

Volltext

Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study von Paleari, Laura, Rutigliani, Mariangela, Siri, Giacomo, Provinciali, Nicoletta, Colombo, Nicoletta, Decensi, Andrea

Volltext

Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer von Redondo, Andres, Colombo, Nicoletta, McCormack, Mary, Dreosti, Lydia, Nogueira-Rodrigues, Angelica, Scambia, Giovanni, Lorusso, Domenica, Joly, Florence, Schenker, Michael, Ruff, Paul, Estevez-Diz, Maria, Irahara, Natsumi, Donica, Margarita, Gonzalez-Martín, Antonio

Volltext

Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826 von Nishio, Shin, Yonemori, Kan, Usami, Tomoka, Minobe, Shinichiro, Yunokawa, Mayu, Iwata, Takashi, Okamoto, Aikou, Aoki, Yoichi, Itamochi, Hiroaki, Takekuma, Munetaka, Harano, Kenichi, Yamamoto, Keiko, Maruko, Takeshi, Ugai, Hiroyuki, Tekin, Cumhur, Colombo, Nicoletta, Fujiwara, Keiichi, Hasegawa, Kosei, Ushijima, Kimio

Volltext

CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells von Lupia, Michela, Angiolini, Francesca, Bertalot, Giovanni, Freddi, Stefano, Sachsenmeier, Kris F., Chisci, Elisa, Kutryb-Zajac, Barbara, Confalonieri, Stefano, Smolenski, Ryszard T., Giovannoni, Roberto, Colombo, Nicoletta, Bianchi, Fabrizio, Cavallaro, Ugo

Volltext

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup von BOOKMAN, Michael A, BRADY, Mark F, MUTCH, David G, BURGER, Robert A, SWART, Ann Marie, TRIMBLE, Edward L, ACCARIO-WINSLOW, Chrisann, ROTH, Lawrence M, MCGUIRE, William P, HARPER, Peter G, ALBERTS, David S, FRIEDLANDER, Michael, COLOMBO, Nicoletta, FOWLER, Jeffrey M, ARGENTA, Peter A, DE GEEST, Koen

Volltext

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling von Giordano, Marco, Decio, Alessandra, Battistini, Chiara, Baronio, Micol, Bianchi, Fabrizio, Villa, Alessandra, Bertalot, Giovanni, Freddi, Stefano, Lupia, Michela, Jodice, Maria Giovanna, Ubezio, Paolo, Colombo, Nicoletta, Giavazzi, Raffaella, Cavallaro, Ugo

Volltext